SEC Form 4 · accession 0001662252-17-000080
Rich Pharmaceuticals, Inc. · RCHA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ben Chang
Officer — CEO, CFO, Pres · Director · 10% Owner
Period of report
Mar 30, 2017
Accepted (ET)
Apr 6, 2017 · 1:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504389
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 30, 2017 | A | 3,000,000,000 | $0.00 | A | 3,335,419,751 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2 | $0.0001 | Mar 30, 2017 | A | 100,000,000 | A | Mar 30, 2017 | Mar 29, 2022 | Common Stock | 100,000,000 | 153,246,000 | D |
Explanation of responses
- F1On March 30, 2017, the Issuer agreed to convert the amount of $300,000 of accrued salary owed to the Reporting Owner into 3,000,000,000 restricted shares of the Issuer's common stock based on the conversion price of $.0001 per share.
- F2On March 30, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2017 Stock Option / Stock Issuance PLan (the "Plan"). The Reporting Owner has the right to 100,000,000 shares of common stock of the Issuer under the Plan at an exercise price of $0.0001. The Option vests immediately, has a 5 year term and may be exercised by cashless exercise.